Welcome to the e-CCO Library Archive!

Filter:
P402. Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
Authors:

T. Molnár1, P.L. Lakatos2, K. Farkas1, A. Bálint1, F. Nagy1, Z. Szepes1, P. Miheller3, K. Palatka4, T. Wittmann1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2Semmelweis University, First Department of Medicine, Budapest, Hungary, 3Semmelweis University, Second Department of Medicine, Budapest, Hungary, 4University of Debrecen, Second Department of Medicine, Debrecen, Hungary

P402

Anal neoplasia in inflammatory bowel disease is associated with HPV and perianal disease

Authors:

J. Ruel*1, M. Ko2, N. Patil2, B. Jharap1, D. Zhang2, G. Roda1, N. Harpaz1, J.-F. Colombel3

1Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, United States, 2Icahn School of Medicine at Mount Sinai, Medicine, New York, United States, 3Icahn School of Medicine at Mount Sinai, Division of Gastroenterology, New York, New York, United States

P403.

Normalisation of faecal calprotectin is an absolute marker of mucosal healing and predicts long-term remission in ulcerative colitis (UC)

Authors:

B. Hayee, P. Dubois, G. Chung-Faye, I. Bjarnason, King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom

P403. Adalimumab sustains deep remission for 3 years: Data from CHARM and ADHERE
P403. Predictors of relapse after discontinuing anti-TNF therapy in Crohn's disease patients on deep remission
Authors:

A. Echarri1, V. Ollero1, J.A. Rodriguez1, J.C. Gallego2, J. Castro1, 1Complejo Hospitalario Universitario de Ferrol, Gastroenterology, Spain, 2Complejo Hospitalario Universitario de Ferrol, Radiology, Spain

P403

Colectomy is not a cure for ulcerative colitis: A systematic review

Authors:

L. Peyrin-Biroulet*1, A.S. Patel2, J.O. Lindsay3

1Nancy University Hospital, Université de Lorraine, Inserm U954 and Department of Gastroenterology, Vandouvre-les-Nancy, France, 2Abacus International, Systematic Review, Bicester, United Kingdom, 3The Royal London Hospital, Barts Health NHS Trust Department of Gastroenterology, London, United Kingdom

P404.

Normal CRP remission as an outcome parameter in pediatric Crohn's disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes With Therapy” (GROWTH CD) cohort study

Authors:

M. Sladek1, D. Turner2, T. Pfeffer Gik3, J. Amil Dias4, G. Veres5, R. Shaoul6, A. Staiano7, J. Escher8, K.-L. Kolho9, A. Paerregaard10, J. Martin de Carpi11, G. Veereman Wauters12, S. Koletzko13, O. Shevah3, L. Finnby14, A. Levine3, 1Jagiellonian University Medical College, Department of Pediatrics, Gastroenterology and Nutrition, Krakow, Poland, 2Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Pediatric Gastroenterology, Jerusalem, Israel, 3Wolfson Medical Center, Tel Aviv University, Pediatric Gastroenterology, Tel Aviv, Israel, 4Hospital, S. Joao, Department of Pediatrics, Porto, Portugal, 5Semmelweis University, Pediatric Gastroenterology, Budapest, Hungary, 6Meyer Children's Hospital, Pediatric Gastroenterology, Haifa, Israel, 7University of Naples “Federico II”, Pediatrics, Naples, Italy, 8Erasmus MC-Sophia Children's Hospital, Pediatric Gastroenterology, Rotterdam, Netherlands, 9Children's Hospital, Helsinki University Central Hospital, Pediatric Gastroenterology, Helsinki, Finland, 10Hvidovre Hospital, Pediatrics, Hvidovre, Denmark, 11Hospital Sant Joan de Déu, Pediatric Gastroenterology, Barcelona, Spain, 12University Hospital UZ Brussels, Pediatric Gastroenterology, Brussels, Belgium, 13Dr. v Haunersches Kinderspital, Ludwig Maximilians University Munich, Pediatric Gastroenterology, Munich, Germany, 14Lovisenberg Diakonale Hospital, Unger-Vetlesens Institute, Oslo, Norway

P404. Acute severe ulcerative colitis: The last twelve years in Edinburgh
P404. Predictors of long-term relapse-free and colectomy-free survival in patients with ulcerative colitis treated with infliximab
Authors:

M. Ferrante1, M.T. Arias1, S. Vermeire1, M. Noman1, G. Van Assche1, A. Wolthuis2, A. De Buck Van Overstraeten2, V. Ballet1, A. Gils3, I. Hoffman4, A. D'Hoore2, P. Rutgeerts1, 1University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium, 2University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium, 3University Hospitals Leuven, Department of Pharmaceutical Biology, Leuven, Belgium, 4University Hospitals Leuven, Department of Paediatric Gastroenterology, Leuven, Belgium

P404

Calcineurin inhibitors are safe and effective for induction of remission in patients commencing vedolizumab for IBD

Authors:

B. Christensen*, S.R. Goeppinger, R. Colman, D. Siddiqui, A. Yarur, A. Hirsch, A.A. Bochenek, A. Wichmann, A. Sakuraba, R. Cohen, D.T. Rubin

University of Chicago Inflammatory Bowel Disease Center, Gastroenterology, Chicago, IL, United States

P405.

Mucosal healing in patients with ulcerative colitis treated with infliximab. What happens after treatment is discontinued?

Authors:

C. Muñoz Villafranca, M.T. Bravo Rodríguez, J. Ortiz de Zárate, P. Arreba González, I. García Kamiruaga, J. Heras Martín, P. Cabezudo Gil, V. Orive Cura, Hospital universitario de Basurto, Aparato digestivo, Bilbao, Spain

P405. Microscopic colitis – a population-based study from Uppsala health region in Sweden
P405. Predictors of endoscopic recurrence in a long term follow up cohort of Crohn's disease patients – How effective is azathioprine? A single tertiary referral center experience
Authors:

Y. Erzin1, G. Sisman1, I. Hatemi1, B. Baca2, I. Hamzaoglu3, A. Dirican4, A.F. Celik1, 1Istanbul University Cerrahpasa Medical Faculty, Gastroenterology, Istanbul, Turkey, 2Istanbul University Cerrahpasa Medical Faculty, Surgery, Istanbul, Turkey, 3Istanbul Univesrity Cerrahpasa Medical Faculty, Surgery, Istanbul, Turkey, 4Istanbul University Istanbul Medical faculty, Biostatistics, Turkey

P405

Pediatric Crohn's disease with iron deficiency anemia: A follow-up study of intravenous iron treatment

Authors:

S. Valério de Azevedo*, C. Maltez, A.I. Lopes

Unit of Gastrenterology, Department of Pediatrics, Santa Maria Hospital - CHLN, Academic Medical Center of Lisbon, Lisbon, Portugal

P406.

Mucosal healing in children with Crohn's disease on long term maintenance treatment

Authors:

R. Muhammed, R. Bremner, W. Theodoric, S. Protheroe, S. Murphy, Birmingham Children's Hospital, Paediatric Gastroenterology, Birmingham, United Kingdom

P406. A European Crohn's and ulcerative colitis patient life IMPACT survey
P406. Predictive factors of refractory to tacrolimus therapy in patients with active ulcerative colitis
Authors:

Y. Yokoyama1, K. Watanabe2, N. Hida1, K. Nogami1, K. Kamikozuru1, K. Tozawa1, K. Nagase1, K. Fukunaga1, T. Matsumoto1, 1Hyogo College of Medicine, Department of Internal Medicine, Division of Lower Gastroenterology, Nishinomiya, Japan, 2Graduate School of Medicine, Osaka City University, Department of Gastroenterology, Osaka, Japan

P406

Adipose derived regenerative cells injection as a novel method of enterovesical fistula treatment in Crohn's Disease: A case report

Authors:

A. Moniuszko*1, A. Sarnowska2, W. Rogowski3, M. Durlik4, 5, G. Rydzewska1, 5

1Central Clinical Hospital of the Ministry of Internal Affairs, Department of Gastroenterology, Warsaw, Poland, 2Polish Academy of Sciences - Mossakowski Medical Research Center, Translative Platform for Regenerative Medicine, Warsaw, Poland, 3Central Clinical Hospital of the Ministry of Internal Affairs, Clinic of Urology and Oncological Urology, Warsaw, Poland, 4Central Clinical Hospital of the Ministry of Internal Affairs, Department of Gastroenterology and Transplant Surgery, Warsaw, Poland, 5Polish Academy of Sciences - Mossakowski Medical Research Center, Department of Surgical Research and Transplantology, Warsaw, Poland

P407.

Mucosal healing during the clinical remission in patients with ulcerative colitis

Authors:

A. Atanassova1, I. Kotzev2, P. Genev3, V. Velikova4, 1Medical University, Gastroenterology, Varna, Bulgaria, 2Medical University Varna, Gastroenterology, Varna, Bulgaria, 3Medical University Varna, Patology, Varna, Bulgaria, 4University of Economics, Department of Statistics, Varna, Bulgaria

P407. Phenotypic concordance in familial inflammatory bowel disease (IBD)